Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CYCS pseudogene 27 (CYCSP27), also referred to as HCP27, is annotated in some genetic databases as a pseudogene related to the cytochrome c, somatic (CYCS) gene family. Pseudogenes are stretches of DNA that resemble functional genes but are generally non-coding and lack biological activity due to mutations or truncations. There is no evidence to support that CYCSP27 or HCP27 encodes a functional protein, plays a role in human biology, or acts as a therapeutic target. The designation “HCP27” can cause confusion because it closely resembles established gene/protein abbreviations such as HSP27 (heat shock protein 27)[1][2][3], but CYCSP27/HCP27 is not connected to these proteins. No biological function, role in disease, or pharmacological information exists for this pseudogene. - If you intended "HCP27" as a synonym for HSP27 (heat shock protein 27), that is a well-studied protein chaperone with roles in apoptosis, stress responses, and several diseases including cancer and neuropathy[1][2][3]. - If you specifically mean "CYCS pseudogene 27 / CYCSP27," there is no recognized scientific or clinical information on it as a protein or drug target. Summary: The entry "CYCS pseudogene 27 (CYCSP27, HCP27)" is not a characterized therapeutic target; it refers to a pseudogene lacking known biological or medical relevance. If a therapeutic target is intended, the information as provided is likely incorrect or a result of nomenclature confusion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CYCS pseudogene 27 (CYCSP27).